D.C. Police Union backs Trump's federal takeover amid rising crime, sparking partisan clash over public safety solutions.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
D.C. Police Union backs Trump's federal takeover amid rising crime, sparking partisan clash over public safety solutions.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.